| Financial Year |
March 31 2023 |
| Monetary Funds |
3,635,408.58 |
| Held-for-trading Financial Assets |
19,325,737.84 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,185,189.30 |
| Advances to Suppliers |
1,352,278.80 |
| Other Receivables |
208,252,393.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,113,477,515.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,144,619.68 |
| Total Current Assets |
1,352,373,143.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
286,386,248.48 |
| Investment Properties |
624,409,367.55 |
| Fixed Assetes |
1,586,784.42 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
46,911,789.51 |
| Other Non-Current Assets |
2,000,000.00 |
| Sub-Total of Non-Current Assets |
962,384,306.17 |
| Total Assets |
2,314,757,449.19 |
| Short-Term Loans |
179,733,984.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
220,760,497.86 |
| Accounts Received In Advance |
46,888,775.78 |
| Employee Compensation Payable |
947,679.58 |
| Taxes Payable |
211,907,632.13 |
| Interest Payable |
5,882,222.22 |
| Dividend Payable |
-- |
| Other payables |
112,861,940.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,030,241.65 |
| Other Current Liabilities |
244,713,477.65 |
| Sub-Total of Current Liabilities |
1,018,846,901.07 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
27,067.89 |
| Total Liabilities |
1,018,873,968.96 |
| Paid-In Capital(Or Share Stock) |
146,841,890.00 |
| Capital Surplus |
156,951,007.81 |
| Surplus Reserve |
112,453,944.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
794,734,312.85 |
| Minority Stockholder's Interest |
84,902,324.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,210,981,155.60 |
| Owner's Equity（Stockholder's Equity） |
1,295,883,480.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,314,757,449.19 |
